Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07063732 · ClinicalTrials.gov registry record · NA

Ketone Monoester Supplements, High Altitude, and Brain Blood Flow During Exercise

A NA study of Exercise and High Altitude Hypoxia, sponsored by McMaster University.

Recruiting
Registry status
NA
Development phase
14
Enrollment target
2
Study locations

NCT07063732 is a NA study of Exercise and High Altitude Hypoxia that is actively recruiting participants, run by McMaster University. The registered enrollment target is 14 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07063732, a NA study of Exercise and High Altitude Hypoxia, is actively recruiting participants, sponsored by McMaster University.

RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this trial is to investigate the effect of acute ketone monoester ingestion (0.6 g KME/kg body weight) on the occurrence of the ventilatory threshold and the subsequent response of blood velocity in cerebral arteries during a maximal exercise test at low altitude and high altitude.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Ketone Monoester (KME)

Study Locations (2)

California

  • Barcroft Research Station - Bishop

Ontario

  • University of Guelph - Guelph

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2025-05-28
Est. Completion 2025-08-31
Phase NA

Sponsor

McMaster University

31 total trials

What the Registry Record Tells You About NCT07063732

The ClinicalTrials.gov registry entry for NCT07063732 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower). The listed sponsor is McMaster University, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Exercise appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07063732 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Ontario.

Frequently Asked Questions

What is clinical trial NCT07063732 about?

NCT07063732 is a clinical study titled "Ketone Monoester Supplements, High Altitude, and Brain Blood Flow During Exercise". The purpose of this trial is to investigate the effect of acute ketone monoester ingestion (0.6 g KME/kg body weight) on the occurrence of the ventilatory threshold and the subsequent response of blood velocity in cerebral arteries during a maximal exercise test at low altitude and high altitude.

What is the current status of trial NCT07063732?

This trial is currently recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2025-05-28. Estimated completion is 2025-08-31.

What conditions does trial NCT07063732 study?

This clinical trial studies the following conditions: Exercise, High Altitude Hypoxia.

What interventions are being tested in trial NCT07063732?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Ketone Monoester (KME) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07063732?

This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07063732 being conducted?

This trial has 2 study locations across California, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Exercise

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.